Tumor microenvironment: What can effusions teach us?
暂无分享,去创建一个
[1] J. Whang‐Peng,et al. An analysis of cytokine status in the serum and effusions of patients with tuberculous and lung cancer. , 2001, Lung cancer.
[2] M. Fiegl,et al. Sensitive detection of tumour cells in effusions by combining cytology and fluorescence in situ hybridisation (FISH) , 2004, British Journal of Cancer.
[3] I. Vlachonikolis,et al. Assaying of Tumor Necrosis Factor α, Complement Factors, and α-1-Antitrypsin in the Diagnosis of Malignant Serous Effusions , 2001 .
[4] K. Arimura,et al. Vascular endothelial growth factor and proinflammatory cytokines in pleural effusions. , 2002, Respiratory medicine.
[5] Carlos López-Otín,et al. Matrix metalloproteinases and tumor progression. , 2003, Advances in experimental medicine and biology.
[6] L. Burgess. Biochemical analysis of pleural, peritoneal and pericardial effusions. , 2004, Clinica chimica acta; international journal of clinical chemistry.
[7] Richard W. Light,et al. Transforming Growth Factor β Induces Vascular Endothelial Growth Factor Elaboration from Pleural Mesothelial Cells in Vivo and in Vitro , 2002 .
[8] J. Nesland,et al. Matrix metalloproteinases (MMP), EMMPRIN (extracellular matrix metalloproteinase inducer) and mitogen-activated protein kinases (MAPK): Co-expression in metastatic serous ovarian carcinoma , 2004, Clinical & Experimental Metastasis.
[9] J. Nesland,et al. Interleukin-8 and vascular endothelial growth factor mRNA and protein levels are down-regulated in ovarian carcinoma cells in serous effusions , 2004, Clinical & Experimental Metastasis.
[10] L. Liotta,et al. Tumor cell interactions with the extracellular matrix during invasion and metastasis. , 1993, Annual review of cell biology.
[11] J. Folkman,et al. ISOLATION OF A TUMOR FACTOR RESPONSIBLE FOR ANGIOGENESIS , 1971, The Journal of experimental medicine.
[12] Y. Morishita,et al. Lysophosphatidic Acid (LPA) in Malignant Ascites Stimulates Motility of Human Pancreatic Cancer Cells through LPA1* , 2004, Journal of Biological Chemistry.
[13] B. Hemmerlein,et al. Real-time reverse transcription-polymerase chain reaction assay for GA733-2 mRNA in the detection of metastatic carcinoma cells in serous effusions. , 2003, American journal of clinical pathology.
[14] V. Antony,et al. Pathophysiology of pleural space infections. , 1999, Seminars in respiratory infections.
[15] W. Stetler-Stevenson,et al. Proteases in invasion: matrix metalloproteinases. , 2001, Seminars in cancer biology.
[16] G. Giannelli,et al. Cancer Invasion: Watch Your Neighbourhood! , 2003, Tumori.
[17] Y. Lee,et al. Vascular endothelial growth factor: the key mediator in pleural effusion formation , 2002, Current opinion in pulmonary medicine.
[18] N. Siafakas,et al. Diagnostic value of interleukin-1alpha, interleukin-6, and tumor necrosis factor in pleural effusions. , 2002, Chest.
[19] R. Whitehead,et al. Tissue culture studies of malignant effusions. , 1975, British Journal of Cancer.
[20] G. Mills,et al. Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells. , 2001, Journal of the National Cancer Institute.
[21] Masao Tanaka,et al. A possible role of TGF-β in the formation of malignant effusions , 1995 .
[22] N. Kaneko,et al. Clinical significance of vascular endothelial growth factor in patients with primary lung cancer , 2002, Respirology.
[23] David A. Cheresh,et al. Role of integrins in cell invasion and migration , 2002, Nature Reviews Cancer.
[24] R. Light,et al. Vascular endothelial growth factor level correlates with transforming growth factor-beta isoform levels in pleural effusions. , 2000, Chest.
[25] S. Sone,et al. Vascular endothelial growth factor in malignant pleural effusion associated with lung cancer , 1999, Cancer Immunology, Immunotherapy.
[26] S. Rodenhuis,et al. Malignant effusions contain lysophosphatidic acid (LPA)-like activity. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.
[27] E. Kohn,et al. Granulin‐epithelin precursor is a novel prognostic marker in epithelial ovarian carcinoma , 2004, Cancer.
[28] A. van Dalen,et al. Vascular endothelial growth factor (VEGF) concentration in sera and tumor effusions from patients with ovarian carcinoma. , 2004, Anticancer research.
[29] Z. Darżynkiewicz,et al. Relative abundance and patterns of correlation among six cytokines in pleural fluid measured by cytometric bead array. , 2003, International journal of molecular medicine.
[30] L. Matrisian,et al. Matrix metalloproteinases in tumor-host cell communication. , 2002, Differentiation; research in biological diversity.
[31] G. Mills,et al. The emerging role of lysophosphatidic acid in cancer , 2003, Nature Reviews Cancer.